SABRE: Assessment of safety and efficacy of 64 Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS346-TPS346, 97p
- Subject
- Language
- ISSN
- 0732183X